Mulhern, C. M., Hong, Y., Omoyinmi, E., Jacques, T. S., D'Arco, F., Hemingway, C., . . . Eleftheriou, D. (2019). Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation. J Allergy Clin Immunol.

Mulhern, Ciara M., Ying Hong, Ebun Omoyinmi, Thomas S. Jacques, Felice D'Arco, Cheryl Hemingway, Paul A. Brogan, et Despina Eleftheriou. "Janus Kinase 1/2 Inhibition for the Treatment of Autoinflammation Associated With Heterozygous TNFAIP3 Mutation." J Allergy Clin Immunol 2019.

Mulhern, Ciara M., et al. "Janus Kinase 1/2 Inhibition for the Treatment of Autoinflammation Associated With Heterozygous TNFAIP3 Mutation." J Allergy Clin Immunol 2019.